April 28, 2021 Joseph T. Kennedy Re:Transitional Services and Separation Agreement Dear Joe:Transitional Services and Separation Agreement • April 29th, 2021 • Amarin Corp Plc\uk • Pharmaceutical preparations • California
This letter confirms our agreement regarding your planned retirement and in connection therewith your resignation as EVP, General Counsel and Strategic Initiatives and Secretary of Amarin Corporation plc (the “Company”) and related positions in affiliated companies. The Board of Directors of the Company (the “Board”) appreciates your substantial contributions to the Company and would like to make this transition as seamless as possible.
Re: Transitional Services and Separation Agreement Dear Russ: This letter agreement follows our conversations regarding your employment withTransitional Services and Separation Agreement • November 6th, 2024 • Irobot Corp • Household appliances • Massachusetts
iRobot Corporation (the “Company”). This confirms that you will be transitioning from your role as Executive Vice President Human Resources & Corporate Communications (EVP) of the Company and, ultimately, from your employment with the Company. The Company greatly appreciates your service to the Company and would like to make this transition as smooth as possible. Consistent with that, the Company is offering you an opportunity continue your at-will employment during a transition period and receive pay and benefits in connection therewith.
TRANSITIONAL SERVICES AND SEPARATION AGREEMENT AMONG FIRSTSERVICE CORPORATION AND NEW FSV CORPORATION AND FSV HOLDCO ULC AND FIRSTSERVICE COMMERCIAL REAL ESTATE SERVICES INC. AND OTHERSTransitional Services and Separation Agreement • June 3rd, 2015 • Colliers International Group Inc. • Real estate • Ontario
THIS TRANSITIONAL SERVICES AND SEPARATION AGREEMENT is made effective as of 12:00:01 a.m. (Toronto, Ontario local time) on the 1st day of June, 2015
Re: Transitional Services and Separation AgreementTransitional Services and Separation Agreement • May 8th, 2024 • Anika Therapeutics, Inc. • Surgical & medical instruments & apparatus • Massachusetts
This letter agreement follows our conversations regarding your employment with Anika Therapeutics, Inc. (the “Company”). This confirms that you will be transitioning and resigning from your employment. We appreciate your contributions and would like to work with you to make this transition as smooth as possible. Consistent with that, this letter is to express the parties’ mutual understanding and promises concerning the orderly transition of your responsibilities and the ultimate termination of your employment at the Company.
June 15, 2016 BY HAND AND EMAIL Thomas Brigiotta Re: Transitional Services and Separation Agreement Dear Tom: This confirms the details relating to the ending of your employment at Imprivata, Inc. (“Imprivata” or the “Company”).Transitional Services and Separation Agreement • June 21st, 2016 • Imprivata Inc • Services-prepackaged software • Massachusetts
The Company sincerely appreciates your contributions over the years and would like to make this transition as smooth as possible. If you enter into this Transitional Services Agreement (the “Agreement”) it will fully supersede your prior agreements or understandings with the Company regarding compensation and severance including, without limitation, the April 30, 2014 Employment Agreement (the “Employment Agreement”). In the interest of clarity, your obligations under the Company’s Noncompetition, Nondisclosure and Inventions Agreement dated August 19, 2008 (the “Restrictive Covenant Agreement”) shall continue to be in full force and effect.
AMENDMENT TO TRANSITIONAL SERVICES AND SEPARATION AGREEMENTTransitional Services and Separation Agreement • April 1st, 2021 • Aerpio Pharmaceuticals, Inc. • Pharmaceutical preparations • Ohio
This Amendment to Transitional Services and Separation Agreement (this “Amendment”) is made as of April 1, 2021 (the “Amendment Effective Date”), by and between Kevin G. Peters, MD (“Executive”) and Aerpio Pharmaceuticals, Inc., a Delaware corporation (the “Company”, and together with Executive, each, a “Party”, and collectively, the “Parties”). Capitalized terms used and not otherwise defined herein shall have the meanings ascribed to such terms in the Transitional Services and Separation Agreement (as defined below).
TRANSITIONAL SERVICE AND SEPARATION AGREEMENTTransitional Services and Separation Agreement • January 29th, 2019 • Biodelivery Sciences International Inc • Pharmaceutical preparations • North Carolina
This Transitional Services and Separation Agreement (“Agreement”) is made as of January 23, 2019 between BioDelivery Sciences International, Inc. (the “Company”), and Ernest R. De Paolantonio (“De Paolantonio”). De Paolantonio and the Company may be collectively referred to as the “parties” or individually referred to as a “party.”
Personal and Confidential November 20, 2017 Howard Benjamin, Ph.D. Lexington, MA 02421 Re: Transitional Services and Separation Agreement Dear Howard:Transitional Services and Separation Agreement • November 22nd, 2017 • Repligen Corp • Biological products, (no disgnostic substances) • Massachusetts
This letter confirms that you and Repligen Corporation (“Repligen” or the “Company”) have reached an amicable decision for you to transition from your role as Vice President of Business Development and for your employment relationship to end in accordance with this Transitional Services and Separation Agreement (the “Agreement”). You and the Company thus agree as follows:
Re: Transitional Services and Separation AgreementTransitional Services and Separation Agreement • August 6th, 2020 • AVROBIO, Inc. • Biological products, (no disgnostic substances) • Massachusetts
This letter agreement follows our conversations regarding your employment with AVROBIO, Inc. (the “Company”). This confirms that you will be transitioning from your employment. We appreciate your contributions and would like to work with you to make this transition as smooth as possible. Consistent with that, the Company is offering you an opportunity continue your at-will employment during a transition period and then receive the severance pay and benefits provided in your Employment Agreement with the Company dated as of December 17, 2018 (the “Employment Agreement”). This is the “Separation Agreement and Release” referred to in the Employment Agreement.
Re: Transitional Services and Separation AgreementTransitional Services and Separation Agreement • January 29th, 2024 • Irobot Corp • Household appliances • Massachusetts
This letter agreement follows our conversations regarding your employment with iRobot Corporation (the “Company”). This confirms that you will be transitioning from your roles as Chief Executive Officer and Chairman of the Board of Directors of the Company (the “Board”) and, ultimately, from your employment with the Company. The Company greatly appreciates your years of service to the Company and would like to make this transition as smooth as possible. Consistent with that, the Company is offering you an opportunity continue your at-will employment during a transition period and receive pay and benefits in connection therewith.
March 31, 2021 PERSONAL AND CONFIDENTIAL Jon Naft Re: Transitional Services and Separation Agreement Dear Jon:Transitional Services and Separation Agreement • April 6th, 2021 • Myomo, Inc. • Orthopedic, prosthetic & surgical appliances & supplies • Massachusetts
This letter confirms that the last day of your employment with Myomo, Inc. (the “Company”) will be March 31, 2021 (the “Separation Date”) as a result of your resignation without Good Reason as defined under your Employment Agreement between you and the Company dated December 23, 2016 (the “Employment Agreement”). This letter also proposes an agreement between you and the Company.
TRANSITIONAL SERVICES AND SEPARATION AGREEMENTTransitional Services and Separation Agreement • May 6th, 2015 • Bluebird Bio, Inc. • Biological products, (no disgnostic substances) • Massachusetts
This Transitional Services and Separation Agreement (the “Agreement”) is entered into by and between bluebird bio, Inc., a Delaware corporation (the “Company”) and Mitchell H. Finer, Ph.D. (“Executive”) (together the “Parties”).
THIS TRANSITIONAL SERVICES AND SEPARATION AGREEMENT ("Agreement") is made on the 27th day of May 2015 (the "Effective Date")Transitional Services and Separation Agreement • May 16th, 2016 • Acorn International, Inc. • Retail-miscellaneous retail
The Parties explicitly agree to act in good faith and to do what is in their control as officers, directors and shareholders to ensure performance of their respective obligations under this Agreement.
TRANSITIONAL SERVICES AND SEPARATION AGREEMENTTransitional Services and Separation Agreement • February 16th, 2021 • Aerpio Pharmaceuticals, Inc. • Pharmaceutical preparations • Ohio
This Transitional Services and Separation Agreement (“Agreement”) is made between Aerpio Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Kevin G. Peters, MD (“Executive”). The Company together with Executive shall be referred to as the “Parties”.
Re: Amended and Restated Transitional Services and Separation AgreementTransitional Services and Separation Agreement • September 2nd, 2016 • Repligen Corp • Biological products, (no disgnostic substances) • Massachusetts
This Amended and Restated Transitional Services and Separation Agreement (the “Agreement”) confirms that you and Repligen Corporation (“Repligen” or the “Company”) have reached an amicable decision for you to first transition from your role as Senior Vice President, Research and Development to the role of Senior Advisor to the Company on September 1, 2016, and then for your employment relationship with the Company to end on Feb. 28, 2017, unless you or the Company elects to end your employment on an earlier date in accordance with this Agreement. For purposes of this Agreement, the actual last day of your employment shall be referred to as the “Separation Date.” This Agreement amends, restates and supersedes in all respects the Transitional Services and Separation Agreement between you and the Company dated April 29, 2016 (the “Former Agreement”).
Re: Transitional Services and Separation AgreementTransitional Services and Separation Agreement • March 21st, 2014 • Repligen Corp • Biological products, (no disgnostic substances) • Massachusetts
This confirms that you and the Board of Directors of Repligen Corporation (“Repligen” or the “Company”) have reached an amicable decision for you to transition from your role as Senior Vice President, Global Operations to the role of Senior Advisor to the Company, effective as of July 31, 2014 and then for your employment relationship with the Company to end on July 31, 2015, unless you or the Company elect to end your employment on an earlier date in accordance with this Agreement. For purposes of this Agreement, the actual last day of your employment shall be referred to as the “Separation Date.”
June 29, 2020 Andrew Oh Re:Transitional Services and Separation Agreement Dear Andrew:Transitional Services and Separation Agreement • August 10th, 2020 • Rubius Therapeutics, Inc. • Biological products, (no disgnostic substances) • Massachusetts
This letter confirms that your employment with Rubius Therapeutics, Inc. (the “Company”) will be ending. The Company appreciates your contributions and would like to make this transition as seamless as possible. With this in mind, we are proposing an arrangement that allows you to remain employed by the Company during a transition period, after which you would be eligible to receive certain severance benefits.
TRANSITIONAL SERVICES AND SEPARATION AGREEMENTTransitional Services and Separation Agreement • January 23rd, 2015 • Repligen Corp • Biological products, (no disgnostic substances) • Massachusetts
This Transitional Services and Separation Agreement (the “Agreement”) is entered into by and between Repligen Corporation, a Delaware corporation (the “Company”) and Walter C. Herlihy, Jr. (“Executive”) (together the “Parties”).
